DARLIFARNIB

UNII:	9PE5MSX2YS
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₉H₂₀N₆O
Preferred Substance Name:	DARLIFARNIB
InChIKey:	GWKGWWBQKOIPNP-LJAQVGFWSA-N
GSRS Full Record:	9PE5MSX2YS i

3065226-39-0
(14R)-14-amino-14-(3-methylimidazol-4-yl)-7-oxa-19-azapentacyclo[13.6.2.12,6.19,13.018,22]pentacosa-1(22),2(25),3,5,9,11,13(24),15(23),16,18,20-undecaene-10,20-dicarbonitrile
(14R)-14-amino-14-(3-methylimidazol-4-yl)-7-oxa-19-azapentacyclo[13.6.2.12,6.19,13.018,22]pentacosa-1(22),2(25),3,5,9,11,13(24),15(23),16,18,20-undecaene-10,20-dicarbonitrile
(3S)-3-amino-3-(1-methyl-1H-imidazol-5-yl)-6-oxa-2(4,6)-quinolina-1,4(1,3)-dibenzenacyclohexaphane-22,44-dicarbonitrile
11H,17H-1,18-Etheno-5,9:12,16-dimethenooxacycloheptadecino[8,7-c]pyridine-3,13-dicarbonitrile, 17-amino-17-(1-methyl-1H-imidazol-5-yl)-, (17S)-
DARLIFARNIB [USAN]
Darlifarnib
KO-2806
KO2806
darlifarnib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DARLIFARNIB

Synonyms and Mappings

Resources